CJC 1295 is also known as:
- DAC-GRF (drug affinity complex:growth hormone-releasing factor)
- Modified GRF 1-29
- Mod GRF 1-29
- Sermorelin
- IGF-1 LR3
- Long-acting growth hormone-releasing hormone (GHRH)
- CJC 1295 DAC
It is a synthetic analogue of growth hormone-releasing hormone (GHRH) with improved pharmacokinetics, especially in regard to half-life. CJC 1295 is a potent stimulator of growth hormone (GH) release. It is more potent than GHRH (1-29) and has a longer half-life, meaning that it remains in the bloodstream for a longer period of time.
CJC 1295 is used for a variety of purposes, including:
- Athletic performance enhancement
- Growth hormone deficiency (GHD)
- Aging
- Alzheimer’s disease
- Parkinson’s disease
- Multiple sclerosis
- Spinal cord injury
- Traumatic brain injury
- Sarcopenia
- Cachexia
CJC 1295 is still under investigation, but it is a promising new therapeutic approach for a variety of conditions.
Other peptides that are similar to CJC 1295
There are a number of other peptides that are similar to CJC 1295. These peptides include:
- Ipamorelin
- GHRP-6
- Hexarelin
- Macimorelin
These peptides are all known as growth hormone secretagogues (GHSs). GHSs are peptides that stimulate the release of growth hormone from the pituitary gland.
GHSs are often used in combination with each other to achieve a greater effect. For example, CJC 1295 is often used in combination with Ipamorelin. This combination is known as GHRP-2/Ipamorelin.
Side effects of CJC 1295
CJC 1295 is generally well-tolerated. However, some people may experience side effects such as headache, nausea, dizziness, and injection site reactions.
CJC 1295 can also interact with certain medications, such as insulin and oral hypoglycemic agents. It is important to talk to your doctor before using CJC 1295 if you are taking any medications.
CJC 1295 is a synthetic analogue of growth hormone-releasing hormone (GHRH) with improved pharmacokinetics, especially in regard to half-life. It is a potent stimulator of growth hormone release.
CJC 1295 is used for a variety of purposes, including athletic performance enhancement and the treatment of medical conditions. It is still under investigation, but it is a promising new therapeutic approach.
Other peptides that are similar to CJC 1295 include Ipamorelin, GHRP-6, Hexarelin, and Macimorelin. GHSs are often used in combination with each other to achieve a greater effect.
CJC 1295 is generally well-tolerated, but some people may experience side effects such as headache, nausea, dizziness, and injection site reactions. CJC 1295 can also interact with certain medications. It is important to talk to your doctor before using CJC 1295 if you are taking any medications.
